Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activation
Sheema Almozyan, Dilek Çolak, Fatmah A. Mansour, et al.
International Journal of Cancer (2017) Vol. 141, Iss. 7, pp. 1402-1412
Open Access | Times Cited: 202

Showing 26-50 of 202 citing articles:

Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
Narayanasamy Badrinath, So Young Yoo
Cancers (2019) Vol. 11, Iss. 3, pp. 310-310
Open Access | Times Cited: 78
PD-L1 is overexpressed on breast cancer stem cells through notch3/mTOR axis
Fatmah A. Mansour, Amer Al‐Mazrou, Falah Almohanna, et al.
OncoImmunology (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 75
Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway
Narges Dastmalchi, Mohammad Ali Hosseinpour Feizi, Seyed Mahdi Banan Khojasteh, et al.
Life Sciences (2020) Vol. 259, pp. 118239-118239
Closed Access | Times Cited: 73
Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
Sunny Kumar, Mouli Chatterjee, Pratyasha Ghosh, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1318-1350
Open Access | Times Cited: 51
PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway
Fang Wang, Liqiong Yang, Mintao Xiao, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 43
METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner
Jiaoshun Chen, Haoxiang Zhang, Chaoyang Xiu, et al.
Cancer Letters (2023) Vol. 565, pp. 216222-216222
Closed Access | Times Cited: 26
PD-L1 is highly expressed in ovarian cancer and associated with cancer stem cells populations expressing CD44 and other stem cell markers
Kholoud Alwosaibai, Salmah Aalmri, Miral Mashhour, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 9
PGD2/PTGDR2 Signaling Restricts the Self-Renewal and Tumorigenesis of Gastric Cancer
Bin Zhang, Qingli Bie, Peipei Wu, et al.
Stem Cells (2018) Vol. 36, Iss. 7, pp. 990-1003
Open Access | Times Cited: 80
Long non-coding RNA CCAT2 promotes oncogenesis in triple-negative breast cancer by regulating stemness of cancer cells
Zhen Xu, Cuiui Liu, Qian Zhao, et al.
Pharmacological Research (2020) Vol. 152, pp. 104628-104628
Closed Access | Times Cited: 67
Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
Rosemarie Tremblay‐LeMay, Nasrin Rastgoo, Hong Chang
Journal of Hematology & Oncology (2018) Vol. 11, Iss. 1
Open Access | Times Cited: 66
The critical role of histone lysine demethylase KDM2B in cancer.
Meina Yan, Xinxin Yang, Hui Wang, et al.
PubMed (2018) Vol. 10, Iss. 8, pp. 2222-2233
Closed Access | Times Cited: 66
Breast cancer stem cells: A review of their characteristics and the agents that affect them
Naing Lin Shan, Yoo Sub Shin, Ge Yang, et al.
Molecular Carcinogenesis (2021) Vol. 60, Iss. 2, pp. 73-100
Open Access | Times Cited: 47
Formononetin represses cervical tumorigenesis by interfering with the activation of PD-L1 through MYC and STAT3 downregulation
Jing Ying Wang, Ming Wen Jiang, Ming Yue Li, et al.
The Journal of Nutritional Biochemistry (2021) Vol. 100, pp. 108899-108899
Closed Access | Times Cited: 41
Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
Constanze Banz‐Jansen, Laureen P. Helweg, Barbara Kaltschmidt
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3412-3412
Open Access | Times Cited: 29
Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy
Shanyong Yi, Mei-Zhuo Wei, Ling Zhao
Critical Reviews in Oncology/Hematology (2024) Vol. 196, pp. 104313-104313
Closed Access | Times Cited: 7
PD-1/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies
Menglei Jin, Jun Fang, Jiakuan Peng, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts
Michael McKenna, Sarah A. McGarrigle, Graham P. Pidgeon
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 2, pp. 185-197
Closed Access | Times Cited: 56
GLI1 promotes cancer stemness through intracellular signaling pathway PI3K/Akt/NFκB in colorectal adenocarcinoma
Zhaoting Yang, Chengye Zhang, Wenbo Qi, et al.
Experimental Cell Research (2018) Vol. 373, Iss. 1-2, pp. 145-154
Closed Access | Times Cited: 52
IL-17A secreted from lymphatic endothelial cells promotes tumorigenesis by upregulation of PD-L1 in hepatoma stem cells
Yuanyan Wei, Danfang Shi, Ziwei Liang, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 6, pp. 1206-1215
Closed Access | Times Cited: 49
<p>miR-140-3p Suppresses Cell Growth And Induces Apoptosis In Colorectal Cancer By Targeting PD-L1</p>
Wei Jiang, Tao Li, Jingjing Wang, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 10275-10285
Open Access | Times Cited: 49
Molecular Mechanism of Stem Cell Differentiation into Adipocytes and Adipocyte Differentiation of Malignant Tumor
Kexin Zhang, Xudong Yang, Qi Zhao, et al.
Stem Cells International (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 48
Upregulation of PD-L1 expression in breast cancer cells through the formation of 3D multicellular cancer aggregates under different chemical and mechanical conditions
Shohreh Azadi, Hamidreza Aboulkheyr Es, Sajad Razavi Bazaz, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2019) Vol. 1866, Iss. 12, pp. 118526-118526
Open Access | Times Cited: 47
Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source
Roberto Ruiu, Lidia Tarone, Valeria Rolih, et al.
Progress in molecular biology and translational science (2019), pp. 119-188
Closed Access | Times Cited: 46
XIST and TSIX: Novel Cancer Immune Biomarkers in PD-L1-Overexpressing Breast Cancer Patients
Esraa A. Salama, Reda E. Adbeltawab, H.M. El Tayebi
Frontiers in Oncology (2020) Vol. 9
Open Access | Times Cited: 46

Scroll to top